![Gregory Demopulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Demopulos
Amministratore Delegato presso
OMEROS CORPORATION
Patrimonio netto: 28 M $ in data 31/08/2026
Profilo
Gregory A. Demopulos is the founder of Omeros Corp., founded in 1994, where the title held is Chairman, President & Chief Executive Officer since 2013.
Current jobs include Director at Onconome, Inc., Director at Tessera, Inc., Director at Northwest NeuroNeighborhood, and Trustee at Smead Funds Trust.
Education history includes undergraduate studies at Stanford University and a doctorate from Stanford University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
OMEROS CORPORATION 2,03% | 22/07/2026 | 1.469.308 ( 2,03% ) | 28 M $ | 31/08/2026 |
Posizioni attive di Gregory Demopulos
| Società | Posizione | Inizio |
|---|---|---|
| OMEROS CORPORATION | Amministratore Delegato | 16/06/1994 |
Tessera, Inc.
 Tessera, Inc. SemiconductorsElectronic Technology Provides packaging solutions for the semiconductor industry | Direttore/Membro del Consiglio | - |
Onconome, Inc.
 Onconome, Inc. Medical SpecialtiesHealth Technology Provides development and commercialization of innovative biomarkers | Direttore/Membro del Consiglio | - |
Smead Funds Trust
 Smead Funds Trust Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Direttore/Membro del Consiglio | - |
Northwest NeuroNeighborhood | Direttore/Membro del Consiglio | - |
Formazione di Gregory Demopulos
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
55
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Omeros Corp.
 Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Provides development and commercialization of innovative biomarkers | Health Technology |
Smead Funds Trust
Smead Funds Trust Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tessera, Inc.
Tessera, Inc. SemiconductorsElectronic Technology Provides packaging solutions for the semiconductor industry | Electronic Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwest NeuroNeighborhood |
